Crossmark

ASO Visual Abstract: Efficacy of Poly(ADP-ribose) Polymerase Inhibitors according to Clinical Risk in Newly Diagnosed, Advanced Ovarian Cancer—A Meta-analysis of Phase III Clinical Trials

Crossref DOI link: https://doi.org/10.1245/s10434-025-18601-1

Published Online: 2025-10-30

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Reid-Schachter, Gillian

Bartels, Helena C.

Brennan, Donal J.
License Information

Text and Data Mining valid from 2025-10-30

Version of Record valid from 2025-10-30
More Information

Article History

First Online: 30 October 2025

Disclosure

: The authors declare no conflict of interest or disclosures in relation to this work.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below